Evidence map›Paper›PMID 41817402›Full record

ArticleThe Journal of cell biology2026

Tetraspanin CD82 shapes EGFR signaling outcomes through nanoscale receptor organization.

Sebastian Restrepo Cruz, Michael J Wester, Vernon S Pankratz, Diane S Lidke, Keith A Lidke, Jennifer M Gillette

Abstract read
In one paragraph

Article in The Journal of cell biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sebastian Restrepo CruzDepartment of Pathology, University of New Mexico Health Sciences Center, Albuquerque, NM, USA.ORCID 0009-0005-1165-4282
Michael J WesterDepartment of Mathematics and Statistics, University of New Mexico, Albuquerque, NM, USA.ORCID 0000-0002-3520-7605
Vernon S PankratzDepartment of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM, USA.ORCID 0000-0002-3742-040X
Diane S LidkeDepartment of Pathology, University of New Mexico Health Sciences Center, Albuquerque, NM, USA.ORCID 0000-0001-8533-6029
Keith A LidkeUniversity of New Mexico Comprehensive Cancer Center , Albuquerque, NM, USA.ORCID 0000-0002-9328-4318
Jennifer M GilletteDepartment of Pathology, University of New Mexico Health Sciences Center, Albuquerque, NM, USA.ORCID 0000-0002-2285-5136

Funding

WOMEN'S CANCERS RESEARCH PROGRAMP30CA118100 · NCI · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI Yolanda Sanchez · 2005 to 2026
$57.1M
Unfolded Protein Response and Autophagy in T Helper Cell Effector FunctionP20GM121176 · NIGMS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI Samuel Joseph Endicott · 2017 to 2026
$24.9M
Functional Role of Tetraspanin CD82 in Hematopoietic Stem Cell InteractionsR01HL122483 · NHLBI · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI Jennifer Gillette · 2015 to 2026
$4.2M
Imaging the Early Events in Membrane Receptor SignalingR35GM126934 · NIGMS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI Diane Lidke · 2018 to 2026
$3.1M
American Cancer Society #130675NHLBI NIH HHS R01 HL122483NIH HHS P20 GM121176NIH HHS P30 CA118100NIH HHS R01 HL122483NIH HHS R35 GM126934
6 · The paper itself

Abstract

Tetraspanins are integral membrane proteins that play a crucial role in organizing and regulating cellular signaling by serving as scaffolds that compartmentalize receptors and other signaling molecules within membrane microdomains. Here, we report how the tetraspanin CD82 modulates the molecular organization and signaling of the EGF receptor (EGFR), a key molecule involved in cellular proliferation, differentiation, and survival. Combining multicolor super-resolution microscopy with advanced image reconstruction and analysis techniques, we demonstrate that CD82 selectively associates with EGFR, promotes receptor oligomerization, and acts as a regulator of ligand-independent receptor phosphorylation in a palmitoylation-dependent manner. Additionally, CD82 promotes a more compact molecular organization of EGFR, which correlates with altered endocytosis and downstream signaling outcomes. These findings underscore the importance of tetraspanins in the spatial and functional regulation of cell surface receptors, with implications for controlling aberrant signaling in disease and positions CD82 as a potential target for developing therapeutic strategies aimed at modulating EGFR signaling by influencing receptor organization.

Indexed as

ErbB ReceptorsKangai-1 ProteinSignal TransductionAnimalsEndocytosisHumansLipoylationMembrane MicrodomainsPhosphorylationCD82 protein, humanEGFR protein, humanErbB ReceptorsKangai-1 Protein

Identifiers

PMID41817402
PMCPMC13045677

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.